Search results for " ESBL"

showing 6 items of 6 documents

Extraintestinal pathogenic Escherichia coli sequence type 131 H30-R and H30-Rx subclones in retail chicken meat, Italy

2016

Extraintestinal pathogenic Escherichia coli sequence type 131 (ST131), typically fluoroquinolone-resistant (FQ-R) and/or extended-spectrum β-lactamase (ESBL)-producing, has emerged globally. Among clinical isolates, ST131, primarily its H30-R and H30-Rx subclones, accounts for most antimicrobial-resistant E. coli and is the dominant E. coli strain worldwide. We assessed its prevalence and characteristics among raw chicken meat samples on sale in Palermo, Italy. A collection of 237 fluoroquinolone resistant and ESBL/AmpC producing E. coli isolates, which had been isolated from processed retail chicken meat in the period May 2013-April 2015, was analyzed. Established polymerase chain reaction…

0301 basic medicineFimH30MeatAFLPST131Settore MED/17 - Malattie InfettiveAnimal foodExtraintestinal Pathogenic Escherichia colichicken030106 microbiologyBiologySettore MED/42 - Igiene Generale E ApplicataMicrobiologyH30-RxMicrobiologylaw.invention03 medical and health sciencesColi strainQuinolone resistanceChicken meatlawDrug Resistance BacterialAnimalsEscherichia coli sequence type 131Amplified Fragment Length Polymorphism AnalysisSafety Risk Reliability and QualityhumansPolymerase chain reactionPhylogenyExPECExtraintestinal Pathogenic Escherichia coliPhylogenetic treeGenetic heterogeneityE. coliGeneral Medicineβ-lactamaseItalyESBLFood MicrobiologyAFLP; Chicken meat; E. coli; ESBL; ExPEC; FimH30; H30-R; H30-Rx; ST131; Food Science; Microbiology; Safety Risk Reliability and QualityE.coliAmplified fragment length polymorphismChickensH30-RFluoroquinolonesPlasmidsFood Science
researchProduct

Outbreak of colonizations by extended-spectrum β-lactamase-producing Escherichia coli sequence type 131 in a neonatal intensive care unit, Italy

2013

Abstract Background Extended spectrum β-lactamases (ESBLs) often associated with resistance to aminoglycosides and fluoroquinolones have recently emerged in community-associated Escherichia coli. The worldwide clonal dissemination of E. coli sequence type (ST)131 is playing a prominent role. We describe an outbreak of colonizations by ESBL-producing E. coli (ESBL-E. coli) in the neonatal intensive care unit (NICU) of the University Hospital, Palermo, Italy. Methods An epidemiological investigation was conducted with the support of molecular typing. All children admitted to the NICU and colonized by ESBL-E. coli between January and June 2012, were included in the study. Cases were defined as…

Microbiology (medical)NICUmedicine.medical_specialtyNeonatal intensive care unitST131business.industryTransmission (medicine)EpidemiologyResearchPublic Health Environmental and Occupational HealthOutbreakDrug resistancemedicine.disease_causeMicrobiologyInfectious DiseasesMedical microbiologyEpidemiologymedicineInfection controlmulti-drug resistance E.coli ESBLPharmacology (medical)ESBL-Escherichia colibusinessEscherichia coliAntimicrobial Resistance and Infection Control
researchProduct

Comparison of multidrug-resistant extraintestinal pathogenic Escherichia coli from human, foods and animals to investigate the possible chains of tra…

Background Globally, antimicrobial drug resistant Escherichia coli is the most common etiological agent of invasive disease in humans. In Europe, increasing proportions of infections due to third generation cephalosporins (3GCs) and/or fluoroquinolone resistant extraintestinal pathogenic E. coli (ExPEC) strains are reported. It has been shown that multidrug resistant (MDR) E. coli can be transmitted from animals to humans and based on existing evidence, poultry is the food animal source most closely linked to human E. coli. However, lack of reliable data makes it difficult to assess the attributable risk of different food sources and their impact on human health. Objectives In the present s…

E. coli ST131 ExPEC chicken meat ESBL fimH30 Raman Spectroscopy ERIC-PCR MDR
researchProduct

Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapene…

2020

Background: Experience in real clinical practice with ceftazidime-avibactam for the treatment of serious infections due to gram&minus

Nosocomial pneumonia0301 basic medicineMicrobiology (medical)medicine.medical_specialtymedicine.drug_classmedicine.medical_treatment030106 microbiologyAntibioticscarbapenem-sparing regimenBiologymedicine.disease_causeBiochemistryMicrobiologyArticleCarbapenem-sparing regimen; Ceftazidime-avibactam; ESBL-producing Enterobacterales; Nosocomial pneumonia; Pseudomonas aeruginosa03 medical and health sciences0302 clinical medicineESBL-producing EnterobacteralesCarbapenem-sparing regimenInternal medicinemedicinePharmacology (medical)030212 general & internal medicineRenal replacement therapyGeneral Pharmacology Toxicology and PharmaceuticsRisk factorAdverse effectESBL-producing Enterobacterales; Pseudomonas aeruginosa; carbapenem-sparing regimen; ceftazidime-avibactam; nosocomial pneumoniaCeftazidime-avibactamPseudomonas aeruginosaceftazidime-avibactamnosocomial pneumonialcsh:RM1-950medicine.diseaseCeftazidime/avibactamPneumonialcsh:Therapeutics. PharmacologyInfectious DiseasesEndocrinologyBacteremiaPseudomonas aeruginosaESBL-producing Enterobacteralemedicine.drugAntibiotics
researchProduct

Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing

2020

Abstract Background Few data are reported in the literature about the outcome of patients with severe extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) infections treated with ceftolozane/tazobactam (C/T), in empiric or definitive therapy. Methods A multicenter retrospective study was performed in Italy (June 2016–June 2019). Successful clinical outcome was defined as complete resolution of clinical signs/symptoms related to ESBL-E infection and lack of microbiological evidence of infection. The primary end point was to identify predictors of clinical failure of C/T therapy. Results C/T treatment was documented in 153 patients: pneumonia was the most common diagnosis (n = 46…

medicine.medical_specialtyceftolozane/tazobactammedicine.medical_treatmentCRRTTazobactamEnterobacteralesEnterobacteraleInternal medicineCRRT; ESBL; Enterobacterales; ceftolozane/tazobactam; septic shockMajor ArticlemedicineClinical endpointRenal replacement therapybusiness.industrySeptic shockRetrospective cohort studyOdds ratiomedicine.diseaseCeftolozane/tazobactam; CRRT; Enterobacterales; ESBL; Septic shockAcademicSubjects/MED00290Infectious DiseasesOncologyESBLseptic shockCeftolozanebusinessEmpiric therapymedicine.drugOpen forum infectious diseases
researchProduct

Populations of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae are different in human-polluted environment and foo…

2021

Abstract Objectives To assess the extent to which food items are a source of extended-spectrum β-lactamase (ESBL) -producing Escherichia coli (ESBL-Ec) and ESBL-producing Klebsiella pneumoniae (ESBL-Kp) for humans in five European cities. Methods We sampled 122 human polluted (hp)-environments (sewers and polluted rivers, as a proxy of human contamination) and 714 food items in Besancon (France), Geneva (Switzerland), Sevilla (Spain), Tubingen (Germany) and Utrecht (The Netherlands). A total of 254 ESBL-Ec and 39 ESBL-Kp isolates were cultured. All genomes were fully sequenced to compare their sequence types (ST) and core genomes, along with the distribution of blaESBL genes and their genet…

Microbiology (medical)Veterinary medicineKlebsiella pneumoniaeEscherichia coli K. pneumoniae ESBL food environmentBiologyEnvironmentPolluted environmentmedicine.disease_causebeta-LactamasesK. pneumoniae03 medical and health sciencesFood chainPlasmidData sequencesExtended-spectrum β-lactamasemedicinepolycyclic compoundsEscherichia coliHumansEscherichia coliEscherichia coli Infections030304 developmental biologyddc:6160303 health sciences030306 microbiologyK pneumoniaeGeneral MedicineSequence typesbiochemical phenomena metabolism and nutritionbiology.organism_classificationbacterial infections and mycoses3. Good healthAnti-Bacterial AgentsKlebsiella InfectionsKlebsiella pneumoniaeInfectious Diseases[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyESBLFoodbacteria[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyPlasmids
researchProduct